1. Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse. (18th December 2018) Authors: Shebley, Mohamad; Menon, Rajeev M.; Gibbs, John P.; Dave, Nimita; Kim, Su Y.; Marroum, Patrick J. Journal: Journal of clinical pharmacology Issue: Volume 59:Number 5(2019) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy. Issue 2 (3rd March 2021) Authors: Handunnetti, Sasanka; Anderson, Mary Ann; Roberts, Andrew W.; Davids, Matthew S.; Ma, Shuo; Boyer, Michelle; Arzt, Jennifer; Masud, Abdullah Al; Popovic, Relja; Jacobson, Amanda; Kim, Su Y.; Seymour, John F. Journal: EJHaem Issue: Volume 2:Issue 2(2021) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Factors Influencing Intravitreal Bevacizumab and Triamcinolone Treatment in Patients with Diabetic Macular Edema. Issue 6 (8th November 2017) Authors: Kim, Tai K.; Shin, Hye Y.; Kim, Su Y.; Lee, Young C.; Lee, Mee Y. Journal: European journal of ophthalmology Issue: Volume 27:Issue 6(2017) Page Start: 746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Suppression of the TRIF‐dependent signaling pathway of TLRs by epoxomicin. Issue 9 (31st May 2021) Authors: Kim, Su Y.; Shin, Seokwon; Kwon, Minji; Youn, Daniel; Sung, Nam J.; Kim, Na H.; Park, Sin‐Aye; Youn, Hyung‐Sun Journal: Archiv der Pharmazie Issue: Volume 354:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗